Structure Therapeutics American Stock Price Prediction
| GPCR Stock | 89.51 0.06 0.07% |
Momentum 64
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.02) | EPS Estimate Current Year (1.37) | EPS Estimate Next Year (1.38) | Wall Street Target Price 107.8 | EPS Estimate Current Quarter (0.37) |
Using Structure Therapeutics hype-based prediction, you can estimate the value of Structure Therapeutics American from the perspective of Structure Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Structure Therapeutics using Structure Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Structure using crowd psychology based on the activity and movement of Structure Therapeutics' stock price.
Structure Therapeutics Short Interest
An investor who is long Structure Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Structure Therapeutics and may potentially protect profits, hedge Structure Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 31.7043 | Short Percent 0.1141 | Short Ratio 2.66 | Shares Short Prior Month 4.9 M | 50 Day MA 58.4907 |
Structure Therapeutics Hype to Price Pattern
Investor biases related to Structure Therapeutics' public news can be used to forecast risks associated with an investment in Structure. The trend in average sentiment can be used to explain how an investor holding Structure can time the market purely based on public headlines and social activities around Structure Therapeutics American. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Structure Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Structure Therapeutics.
Structure Therapeutics Implied Volatility | 1.12 |
Structure Therapeutics' implied volatility exposes the market's sentiment of Structure Therapeutics American stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Structure Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Structure Therapeutics stock will not fluctuate a lot when Structure Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Structure Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Structure because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Structure Therapeutics after-hype prediction price | USD 89.51 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Structure contract
Based on the Rule 16, the options market is currently suggesting that Structure Therapeutics American will have an average daily up or down price movement of about 0.07% per day over the life of the 2026-04-17 option contract. With Structure Therapeutics trading at USD 89.51, that is roughly USD 0.0627 . If you think that the market is fully incorporating Structure Therapeutics' daily price movement you should consider acquiring Structure Therapeutics American options at the current volatility level of 1.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Structure | Build AI portfolio with Structure Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Structure Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Structure Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Structure Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Structure Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Structure Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Structure Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Structure Therapeutics' historical news coverage. Structure Therapeutics' after-hype downside and upside margins for the prediction period are 75.79 and 103.23, respectively. We have considered Structure Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Structure Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Structure Therapeutics is based on 3 months time horizon.
Structure Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Structure Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Structure Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Structure Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.32 | 13.81 | 12.48 | 0.22 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
89.51 | 89.51 | 0.00 |
|
Structure Therapeutics Hype Timeline
Structure Therapeutics is currently traded for 89.51. The entity has historical hype elasticity of -12.48, and average elasticity to hype of competition of -0.22. Structure is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 2.32%. %. The volatility of related hype on Structure Therapeutics is about 14385.42%, with the expected price after the next announcement by competition of 89.29. About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.66. Structure Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Structure Therapeutics Basic Forecasting Models to cross-verify your projections.Structure Therapeutics Related Hype Analysis
Having access to credible news sources related to Structure Therapeutics' direct competition is more important than ever and may enhance your ability to predict Structure Therapeutics' future price movements. Getting to know how Structure Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Structure Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EWTX | Edgewise Therapeutics | (0.19) | 21 per month | 4.02 | 0.18 | 14.33 | (5.57) | 38.85 | |
| VRDN | Viridian Therapeutics | (0.55) | 8 per month | 1.10 | 0.23 | 5.57 | (2.19) | 15.86 | |
| QURE | Uniqure NV | 0.47 | 10 per month | 0.00 | (0.13) | 9.37 | (10.75) | 60.67 | |
| OCUL | Ocular Therapeutix | (0.75) | 11 per month | 2.78 | (0.01) | 6.04 | (4.80) | 35.70 | |
| NUVB | Nuvation Bio | 0.09 | 9 per month | 4.57 | 0.08 | 7.33 | (5.78) | 68.61 | |
| GLPG | Galapagos NV ADR | 0.82 | 3 per month | 1.27 | 0.04 | 2.62 | (2.52) | 7.08 | |
| MESO | Mesoblast | 0.10 | 9 per month | 2.99 | 0.04 | 5.49 | (3.93) | 19.08 | |
| LQDA | Liquidia Technologies | (0.20) | 8 per month | 3.01 | 0.25 | 8.00 | (4.45) | 19.63 | |
| CLDX | Celldex Therapeutics | (0.81) | 8 per month | 2.90 | (0.02) | 6.44 | (5.22) | 13.96 | |
| ABCL | Abcellera Biologics | 0.06 | 10 per month | 0.00 | (0.11) | 5.90 | (8.62) | 22.32 |
Structure Therapeutics Additional Predictive Modules
Most predictive techniques to examine Structure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Structure using various technical indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Structure Therapeutics Predictive Indicators
The successful prediction of Structure Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Structure Therapeutics American, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Structure Therapeutics based on analysis of Structure Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Structure Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Structure Therapeutics's related companies. | 2023 | 2024 | 2026 (projected) | Current Ratio | 19.14 | 24.74 | 12.21 | Net Debt To EBITDA | 1.21 | 1.05 | 1.44 |
Pair Trading with Structure Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Structure Stock
Moving against Structure Stock
| 0.81 | SLN | Silence Therapeutics PLC Downward Rally | PairCorr |
| 0.73 | DRMA | Dermata Therapeutics | PairCorr |
| 0.64 | FSTF | First State Financial | PairCorr |
| 0.61 | MREO | Mereo BioPharma Group | PairCorr |
| 0.57 | REVB | Revelation Biosciences | PairCorr |
| 0.57 | AMRN | Amarin PLC | PairCorr |
The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.
The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.